Assignee
SHENZHEN ENDURING BIOTECH LTD
CN·2 granted patents·6 pending applications·2 citations·filing 2017–2023
Top patents by PatentIndex Score
8 records- 0175US11065342B2Long acting multi-specific molecules and related methodsSHENZHEN ENDURING BIOTECH LTD·Filed 2017·Granted Jul 20, 2021·2 cites·16 claims
- 0261US12427203B2Long acting multi-specific molecules and related methodsSHENZHEN ENDURING BIOTECH LTD·Filed 2021·Granted Sep 30, 2025·0 cites·14 claims
- 0352US2025295804A1Peg based anti-cd47/anit-pd-l1 bispecific antibody-drug conjugateSHENZHEN ENDURING BIOTECH LTD·Filed 2023·Application pending·0 cites
- 0450US2024181074A1Pegylated t cell engager with dual specificities to cd3 and cd19SHENZHEN ENDURING BIOTECH LTD·Filed 2022·Application pending·0 cites
- 0549US2023391867A1Long acting bi-specific t cell engagers targeting cd3 and cd47SHENZHEN ENDURING BIOTECH LTD·Filed 2021·Application pending·0 cites
- 0648US2026007763A1Pegylated antibody hydroxyl-bearing drug conjugateSHENZHEN ENDURING BIOTECH LTD·Filed 2023·Application pending·0 cites
- 0744US2022233711A1Bispecific t-cell engager with cleavable cytokines for targeted immunotherapySHENZHEN ENDURING BIOTECH LTD·Filed 2020·Application pending·0 cites
- 0841US2023104728A1Antibody-drug conjugateSHENZHEN ENDURING BIOTECH LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHENZHEN ENDURING BIOTECH LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →